Improving Docetaxel Chemotherapy
Author Information
Author(s): Engels F K, Sparreboom A, Mathot R A A, Verweij J
Primary Institution: Erasmus MC - Daniel den Hoed Cancer Center Rotterdam
Hypothesis
Can pharmacological strategies optimize docetaxel-based chemotherapy?
Conclusion
Research has identified various strategies to improve the efficacy and reduce the toxicity of docetaxel treatment.
Supporting Evidence
- Docetaxel is effective for various cancers but has significant side effects.
- Weekly administration of docetaxel shows similar efficacy to the standard 3-week schedule.
- Reducing interindividual variability in drug response could improve treatment outcomes.
Takeaway
Doctors are trying to make a cancer medicine called docetaxel work better and be less harmful by changing how it's given and how much is used.
Methodology
This review discusses various pharmacological strategies to optimize docetaxel treatment.
Potential Biases
Potential bias due to the reliance on previously published studies.
Limitations
The review is based on existing studies, which may have small sample sizes and varied populations.
Participant Demographics
Patients with locally advanced or metastatic breast or lung cancer and prostate cancer.
Statistical Information
P-Value
0.0029
Statistical Significance
p=0.0029
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website